↓ Skip to main content

Stem cell therapy for retinal diseases: update

Overview of attention for article published in Stem Cell Research & Therapy, December 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stem cell therapy for retinal diseases: update
Published in
Stem Cell Research & Therapy, December 2011
DOI 10.1186/scrt91
Pubmed ID
Authors

Rubens Camargo Siqueira

Abstract

Distinct stem cell types have been established from embryos and identified in the fetal tissues and umbilical cord blood as well as in specific niches in many adult mammalian tissues and organs such as bone marrow, brain, skin, eyes, heart, kidneys, lungs, gastrointestinal tract, pancreas, liver, breast, ovaries, and prostate. All stem cells are undifferentiated cells that exhibit unlimited self-renewal and can generate multiple cell lineages or more restricted progenitor populations that can contribute to tissue homeostasis by replenishing the cells or to tissue regeneration after injury. The remarkable progress of regenerative medicine in the last few years indicates promise for the use of stem cells in the treatment of ophthalmic disorders. Experimental and human studies with intravitreal bone marrow-derived stem cells have begun. This paper reviews recent advances and potential sources of stem cells for cell therapy in retinal diseases.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Japan 1 2%
China 1 2%
Unknown 60 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 21%
Student > Master 10 16%
Student > Ph. D. Student 9 14%
Student > Bachelor 9 14%
Professor 5 8%
Other 10 16%
Unknown 7 11%
Readers by discipline Count As %
Medicine and Dentistry 21 33%
Agricultural and Biological Sciences 14 22%
Biochemistry, Genetics and Molecular Biology 9 14%
Neuroscience 3 5%
Engineering 2 3%
Other 6 10%
Unknown 8 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2013.
All research outputs
#15,268,549
of 22,705,019 outputs
Outputs from Stem Cell Research & Therapy
#1,328
of 2,410 outputs
Outputs of similar age
#162,988
of 243,731 outputs
Outputs of similar age from Stem Cell Research & Therapy
#4
of 7 outputs
Altmetric has tracked 22,705,019 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,410 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,731 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.